Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Peking University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Xiansheng Pharmaceutical Co.Ltd.Jiangsu Province China
Information provided by:
Peking University
ClinicalTrials.gov Identifier:
NCT00842491
First received: February 11, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2010
  Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)